
Osborne Clarke is proud to announce the appointment of new partner Roderick Nieuwmeyerwho will lead the firm’s Brussels-based EU law practice.
An expert in competition and EU regulatory, Nieuwmeyer brings extensive experience in merger control proceedings and antitrust investigations before the European Commission and national competition authorities. He is also a sector specialist in retail and consumer as well as life sciences and healthcare.
As a Dutch national and a member of the Bars in both Amsterdam and Brussels (EU-list), Nieuwmeyer will work closely with both Osborne Clarke’s Belgian and Dutch offices. He joins the firm’s broader international Competition, antitrust and trade team, which has a pan-European footprint comprising 10 Partners and 30 fee-earners in total. They bring long-standing experience in defending clients’ international interests while delivering clear and pragmatic advice, tailored to their specific circumstance and sector.
Having started his career at the Dutch firm Houthoff in Amsterdam in 2008, Nieuwmeyer moved to Brussels where he worked at the EU law office of CMS for more than a decade. He has an LL.M in European Legal Studies from the College of Europe in Bruges (Belgium) as well as LL.M degrees in European & Public International Law and Dutch Civil Law from Leiden University (the Netherlands).
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas